跳至主要内容
临床试验/ACTRN12614001234606
ACTRN12614001234606已完成4 期

Assessing the potential for silver dressings to enhance healing of diabetes-related foot ulcers.

The Royal Melbourne Hospital0 个研究点目标入组 176 人开始时间: 2014年11月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants will need to have a confirmed diagnosis of diabetes and an ulcer distal to the level of the ankle. The ulcer will be of less than 6 weeks duration at the time of recruitment and participants will be 18 years or older.

排除标准

  • Individuals who are pregnant, who have an allergy to silver, Mepilex or Zetuvit, wounds with tendons or underlying osteomyelitis and individuals with a life expectancy of less than 12 weeks will be excluded from the study.

研究者

相似试验